Active Ingredient(s): Tafluprost
FDA Approved: * February 10, 2012
Pharm Company: * MERCK SHARP DOHME
Category: Vision / Eye Health

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Zioptan Overview

Tafluprost (trade names Taflotan by Santen Pharmaceutical and Zioptan by Merck in the US) is a prostaglandin analogue. It is used topically (as eye drops) to control the progression of open-angle glaucoma and in the management of ocular hypertension, alone or in combination with other medication. It reduces intraocular pressure by increasing the outflow of aqueous fluid from the eyes.[1][2] Contents 1 Adverse effects 2 Interactions 3 Pharmacology 3.1 Mechani...

Read more Zioptan Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Tafluprost

Recent Zioptan Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Solution: 0.0015%
  • Solution/drops: 0.0015%
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Zioptan: (2 results)

Sorted by National Drug Code
  • 0006-3931 Zioptan .0045 mg/.3ml Ophthalmic Solution by Merck Sharp & Dohme Corp.
  • 17478-609 Zioptan .0045 mg/.3ml Ophthalmic Solution/ Drops by Akorn, Inc.

Other drugs which contain Tafluprost or a similar ingredient: (1 result)